In April 2025, the US executive administration announced universal 10% tariffs on all imported products, in addition to reciprocal tariffs for select foreign nations. As trade negotiations evolve, it is essential to recognize and evaluate the profound implications these economic policies hold for healthcare systems.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
GlobalData. Impact of Trump tariffs on US medical device market. Medical Device Network https://www.medicaldevice-network.com/analyst-comment/trump-tariffs-us-medical-device-market/ (2024).
Twenter, P. 70% of US medical devices are only available overseas, report finds. Becker’s Hospital Review https://www.beckershospitalreview.com/supply-chain/70-of-us-medical-devices-are-only-available-overseas-report-finds/ (2025).
Robbins, R. Tariffs on Medicines from Europe Stand to Cost Drugmakers Billions. The New York Times (28 July 2025).
Cortese, B. D., Dwyer, K., Galloway, L. A. S., Penson, D. F. & Talwar, R. Drug shortages demand action: policy changes to protect patient care. J. Clin. Oncol. 43, 1852–1855 (2025).
Rakshit, S., Wager, E., Hughes-Cromwick, P., Cox, C. & Amin, K. How does medical inflation compare to inflation in the rest of the economy? Peterson-KFF Health System Tracker https://www.healthsystemtracker.org/brief/how-does-medical-inflation-compare-to-inflation-in-the-rest-of-the-economy/ (2024).
Ranney, M. L., Griffeth, V. & Jha, A. K. Critical supply shortages — the need for ventilators and personal protective equipment during the Covid-19 pandemic. N. Engl. J. Med. 382, e41 (2020).
Miller, F. A., Young, S. B., Dobrow, M. & Shojania, K. G. Vulnerability of the medical product supply chain: the wake-up call of COVID-19. BMJ Qual. Saf. 30, 331–335 (2021).
Office of Inspector General of the US Department of Health and Human Services. Hospital experiences responding to the COVID-19 pandemic: results of a national pulse survey March 23-27, 2020 (US Department of Health and Human Services, 2020).
Masumoto, B. Measuring total-premium inflation for health insurance in the consumer price index. Monthly Labor Review https://doi.org/10.21916/mlr.2024.6 (2024).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Britton, C.J., Cortese, B.D. & Talwar, R. Economic impact of tariffs on healthcare costs in urology. Nat Rev Urol (2025). https://doi.org/10.1038/s41585-025-01084-w
Published:
DOI: https://doi.org/10.1038/s41585-025-01084-w
